Trial Profile
A Phase 2, Multiple-Dose, Pharmacokinetic and Pharmacodynamic Study of RDEA594 in Gout Patients with Hyperuricemia and Gout with Renal Insufficiency
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2012
Price :
$35
*
At a glance
- Drugs Lesinurad (Primary) ; Allopurinol; Oxipurinol
- Indications Gout
- Focus Adverse reactions
- 01 Aug 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 16 Jun 2011 New trial record